The groundbreaking rise of Viagra has consistently remained a benchmark of pharmaceutical success, however its position within the broader sector now triggers questions about potential returns . Alternative versions are undercutting patent protection , prompting concerns that betting website on companies heavily reliant to Viagra's former influence